Sound implementation of human papillomavirus vaccination as a community-randomized trial

Article Properties
  • Language
    English
  • Publication Date
    2008/05/01
  • Journal
  • Indian UGC (journal)
  • Refrences
    29
  • Citations
    5
  • M Lehtinen
  • KM French
  • J Dillner
  • J Paavonen
  • G Garnett
Cite
Lehtinen, M, et al. “Sound Implementation of Human Papillomavirus Vaccination As a Community-Randomized Trial”. Therapy, vol. 5, no. 3, 2008, pp. 289-94, https://doi.org/10.2217/14750708.5.3.289.
Lehtinen, M., French, K., Dillner, J., Paavonen, J., & Garnett, G. (2008). Sound implementation of human papillomavirus vaccination as a community-randomized trial. Therapy, 5(3), 289-294. https://doi.org/10.2217/14750708.5.3.289
Lehtinen M, French K, Dillner J, Paavonen J, Garnett G. Sound implementation of human papillomavirus vaccination as a community-randomized trial. Therapy. 2008;5(3):289-94.
Refrences
Title Journal Journal Categories Citations Publication Date
Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries Vaccine
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Medicine (General)
37 2006
New immunization initiatives and progress toward the global control of hepatitis B Current Opinion in Infectious Diseases
  • Medicine: Internal medicine: Infectious and parasitic diseases
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Internal medicine: Infectious and parasitic diseases
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
30 2002
10.1016/S0264-410X(97)00068-6 Vaccine
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Medicine (General)
1997
10.1016/S0264-410X(97)00068-6 2007
10.1016/S0264-410X(97)00068-6 MMWR. Morbidity and Mortality Weekly Report
  • Medicine: Internal medicine: Special situations and conditions: Industrial medicine. Industrial hygiene
  • Medicine: Medicine (General)
2005
Citations
Title Journal Journal Categories Citations Publication Date
Strategies for continuous evaluation of the benefit–risk profile of HPV-16/18-AS04-adjuvanted vaccine Expert Review of Vaccines
  • Medicine: Internal medicine
  • Medicine: Internal medicine: Infectious and parasitic diseases
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
10 2014
Clinical trials of human papillomavirus vaccines and beyond Nature Reviews Clinical Oncology
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
128 2013
Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries

Infectious Diseases in Obstetrics and Gynecology
  • Medicine: Gynecology and obstetrics
  • Medicine: Internal medicine: Infectious and parasitic diseases
12 2011
Prophylactic HPV vaccines: the Finnish perspective Expert Review of Vaccines
  • Medicine: Internal medicine
  • Medicine: Internal medicine: Infectious and parasitic diseases
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
7 2010
Human papillomavirus vaccination and screening as the new paradigm in cervical cancer prevention Therapy 1 2008
Citations Analysis
The category Medicine: Internal medicine: Infectious and parasitic diseases 3 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Human papillomavirus vaccination and screening as the new paradigm in cervical cancer prevention and was published in 2008. The most recent citation comes from a 2014 study titled Strategies for continuous evaluation of the benefit–risk profile of HPV-16/18-AS04-adjuvanted vaccine. This article reached its peak citation in 2014, with 1 citations. It has been cited in 4 different journals, 50% of which are open access. Among related journals, the Expert Review of Vaccines cited this research the most, with 2 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year